Table 2.
Final Model for Vascular Complications in Patients Who Had Transfemoral Arterial Access
| Variable | β | OR | Calibrated β | Calibrated OR | 95% CI for Calibrated OR |
|---|---|---|---|---|---|
| Age (per 10 years) | 0.262 | 1.300 | 0.241 | 1.272 | 1.119 to 1.449 |
| Female (y/n) | 0.980 | 2.664 | 0.902 | 2.464 | 1.845 to 3.289 |
| Troponin elevated (y/n) | 0.713 | 2.041 | 0.656 | 1.927 | 2.509 to 2.584 |
| Chronic kidney disease | |||||
| GFR ≥60 mL min−1 1.73 m2 | Ref | Ref | Ref | Ref | Ref |
| GFR <60 mL min−1 1.73 m2 | 0.245 | 1.278 | 0.225 | 1.252 | 0.914 to 1.718 |
| Dialysis (y/n) | 1.137 | 3.120 | 1.046 | 2.846 | 1.537 to 4.985 |
| Emergent case (y/n) | 0.478 | 1.612 | 0.439 | 1.551 | 1.100 to 2.188 |
| Prior PCI (y/n) | −0.495 | 0.610 | −0.455 | 0.634 | 0.460 to 0.874 |
| PAD (y/n) | 0.549 | 1.732 | 0.505 | 1.657 | 1.187 to 2.316 |
| Diabetes (y/n) | 0.430 | 1.537 | 0.396 | 1.486 | 1.110 to 1.985 |
| Constant | −7.26 | −6.679 | |||
OR indicates odds ratio; CI, confidence interval; GFR, glomerular filtration rate; Ref, reference; PCI, percutaneous coronary intervention; PAD, peripheral artery disease.